Facility fees have become a controversial component of the reimbursement structure for ASCs as some advocates say they disincentivize patients from utilizing lower cost settings for surgical ...
The head of the European office of GV talks about the AI investment cycle and predicts a comeback for Google Glass-style ...
Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...
Liquid biopsies are expanding: Blood tests that can detect cancer are moving beyond just late-stage treatment selection. They ...
Even in 2026, GPT-4 continues to be a major player in the generative AI scene. Released back in 2023, it really set a new bar ...
Insurers must either pay a claim, deny it with a stated reason, or request additional information,” MedChi CEO Gene Ransom ...
A new study says the early U.S. COVID-19 death toll is much higher than official counts, and that there were disparities in ...
The shift toward deep learning in ai agent development. Ever tried to follow a manual that was missing half its pages? That is exactly how old-school ai felt when it hit a "real w ...
Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...